Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: NDoC Pacer 8-29-13 HTC TPL royalty rate/s determination/discus...
$10M for HTC does seem low, but if they can land 50 or so like that over the next couple of years, that's $500M and if PTSC sees say $200M of that then that's 50c a share. Your mileage may vary.
Share
New Message
Please login to post a reply